Correlation analysis of lymphocyte surface antigen and THBS1 levels with myocardial injury in sepsis patients

Read full text Summarise with VIRAT
Authors: Min Wei, Wuchao Wang, Dongxiao Wang, Yifei Cheng, Xiaoyu Liu, Limei Xiu
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: To analyse the relationships among the surface antigens of lymphocytes in patients with sepsis, the level of thrombospondin-1 (THBS1), and myocardial injury. Methods: 360 sepsis patients who were hospitalised in our hospital between January 2023 and January 2025 were chosen. 170 patients with myocardial injury and 190 patients without myocardial injury were selected from the patient group based on whether or not they had myocardial injury. Serum THBS1 levels, immune function (CD4+, CD8+, and CD4+/CD8+), myocardial injury markers [creatine kinase MB (CK-MB), heart-type fatty acid binding protein (H-FABP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and cardiac troponin I (cTnI)], and echocardiographic markers (left ventricular ejection fraction (LVEF), early diastolic velocity to atrial contraction velocity ratio (E/A), and cardiac output (CO)] were compared. Correlations among immune function, THBS1 levels, myocardial injury markers, and echocardiographic markers were examined in individuals with myocardial damage and infection. To predict sepsis in patients with myocardial infarction, serum THBS1 levels were evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC). Results: While the myocardial injury group had significantly lower levels of CD8+ T cells in peripheral blood, LVEF, E/A, and CO, the nonmyocardial injury group had significantly higher levels of CD4+, CD4+/CD8+, serum THBS1, CK-MB, H-FABP, NT-proBNP, and cTnI (P

Fields of Study & Subjects

Sepsis Diagnosis and Treatment Inflammation biomarkers and pathways Takotsubo Cardiomyopathy and Associated Phenomena

Publication details

Journal / source
Journal of Medical Biochemistry
Volume
45
Issue
8
Pages
1732–1740
Publication date
1 January 2026
Language
EN